Induction of Inflammatory Responses in Mice Treated with Cerium Oxide Nanoparticles by Intratracheal Instillation

  • Park Eun-Jung
    College of Pharmacy, Dongduk Women's University
  • Cho Wan-Seob
    Division of Toxicological Research, National Institute of Toxicological Research
  • Jeong Jayoung
    Division of Toxicological Research, National Institute of Toxicological Research
  • Yi Jong-heop
    School of Chemical and Biological Engineering, Seoul National University
  • Choi Kyunghee
    Department of Chemical Assessment, National Institute of Environmental Research
  • Kim Younghun
    Department of Chemical Engineering, Kwangwoon University
  • Park Kwangsik
    College of Pharmacy, Dongduk Women's University

この論文をさがす

抄録

Cerium oxide nanoparticles have a high thermodynamic affinity for oxygen and sulfur, which makes them useful in applications such as catalysts, solar cells, and gas sensors. In this study, we investigated the effects of intratracheal instillation of cerium oxide nanoparticles on the inflammatory responses in mice. The number of neutrophils in bronchoaveolar lavage (BAL) fluids was significantly elevated on day 1 after instillation. Inflammatory cytokines, such as interleukin (IL)-1, tumor necrosis factor (TNF)-α, and IL-6, were also increased in BAL fluid and the cytokine increase initiated the differentiation of naive T cells, followed by the induction of Th1-type cytokines [IL-12 and interferon (IFN)-γ] and Th2-type cytokines (IL-4, IL-5, and IL-10). The secretion of Th1-type cytokines was more dominant than that of Th2-type cytokines. The inflammatory responses were maintained for 28 days by a positive feedback stimulation of IFN-γ and IL-10. In the lung, the expression of inflammatory genes was increased in a time-dependent manner, and granuloma formation appeared on day 14 after instillation. This suggests that intratracheal instillation of cerium oxide nanoparticles causes a delayed-type hypersensitivity reaction and lung fibrosis in mice.

収録刊行物

参考文献 (20)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ